# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Eva Perón (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML025-SYN-TD
- Date: 1951-02-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucía Barragán, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Biopsy result, and gynecologic oncology consultation the same day. **S**

## History of present illness

Ms. Perón returns eight days after her first visit, as arranged, to hear her biopsy result in person; the visit is in Spanish. Before giving the result, Dr. Barragán asked what she understood so far and how she wanted to hear news. She said she suspected something serious, wanted to know everything, directly and herself, and wanted no one else in the room. She was told plainly that the biopsy shows a cancer of the cervix, an invasive squamous cell carcinoma, and that the HPV test found HPV type 16 and the cytology also showed cancer cells. After a pause and some tears she asked whether it can be cured, whether she will be able to work, and whether she could have children. Dr. Osei-Bonsu of gynecologic oncology then joined, with a professional Spanish interpreter, as Ms. Perón agreed. Since the first visit the bleeding has been lighter, she takes the iron daily with dark stools and no stomach upset, and she uses acetaminophen once or twice a day for the pelvic ache. **S**

| Element | Detail |
|---|---|
| Result given | Invasive squamous cell carcinoma of the cervix; HPV 16 positive; cytology with cancer cells |
| How it was given | In person, in Spanish, to her alone, after asking what she wanted to know |
| Her questions | Cure, work, and children |
| Bleeding | Lighter; iron taken daily |
| Scores | Pelvic pain 4 of 10; PHQ-9 9; GAD-7 9 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or weight loss |
| Genitourinary | Positive | Lighter bleeding; no urinary symptoms or blood in the urine |
| Gastrointestinal | Negative | Dark stools on iron; no rectal bleeding or pain on opening the bowels |
| Musculoskeletal | Negative | No back or leg pain; no leg swelling |
| Psychiatric | Positive | Shocked and frightened by the news; no thoughts of self-harm |

5 systems reviewed. **S**

## Current medications

- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairy **S**
- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 112/70 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 52.8 kg; BMI 19.4 kg/m². All vital signs are synthetic.

Creatinine: 0.7 mg/dL; eGFR: 117 mL/min/1.73 m²; Pelvic pain, worst in the past week (0 to 10): 4; PHQ-9: 9; GAD-7: 9. All results are synthetic.

## Change since baseline

- Pelvic pain, worst in the past week (0 to 10): 4 at baseline, 4 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Pale; pulse 90, blood pressure 112/70 |
| Abdomen | Soft; no mass; no enlarged liver |
| Lymph nodes | No inguinal or supraclavicular nodes |
| Pelvic | Examined by Dr. Osei-Bonsu with Ms. Perón's consent and a chaperone: a friable exophytic tumor about 4.5 cm across replacing the cervix; colposcopy of the vagina shows no spread to the vaginal walls; on rectovaginal examination the left parametrium is thickened and nodular but does not reach the pelvic wall; the right parametrium and the rectal mucosa are free |
| Psychiatric | Tearful at first, then composed; asking clear questions; no thoughts of self-harm |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Squamous cell carcinoma of the cervix** (C53.9). Invasive squamous cell carcinoma of the cervix, HPV 16 positive, about 4.5 cm with clinical spread into the left parametrium: at least FIGO 1943 stage IIB on examination. The diagnosis was given to her first, in person and in Spanish, in the way she asked; she chose to hear all of it and to decide herself who else is told. Dr. Osei-Bonsu explained that staging with MRI and PET-CT comes next, that a tumor of this size with parametrial spread is treated with chemoradiation rather than surgery, and that this treatment aims at cure. Fertility and ovarian function were discussed before any treatment: the treatment ends the ability to carry a pregnancy and usually ends ovarian function; egg or embryo freezing would take about two weeks, the ovaries could be moved surgically out of the radiation field, and a gestational carrier would be needed for any later pregnancy. She will decide by the next visit. **S**
   - Pelvic MRI and FDG PET-CT within ten days.
   - HIV and hepatitis C tests today.
   - Fertility decision at the next visit, with reproductive endocrinology seen within days if she wants egg freezing.
   - Oncology social worker met her today; spiritual care offered.
   - She decides what her family and colleagues are told; no information to anyone without her consent.
2. **Abnormal bleeding with a visible cervical mass** (N93.8). Superseded by the diagnosis of cervical cancer today. **S**
   - Problem resolved.
3. **Iron deficiency anemia** (D50.0). Eight days into oral iron; bleeding lighter. A blood count at about one month. **S**
   - Continue ferrous sulfate daily.
   - Blood count at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Disclosure and information preferences: she is told first, in Spanish, as much as she wants to know; she decides who else is told | Every visit | Completed today | Told in person, in Spanish, alone as she asked, after checking what she wanted to know; she asked about cure, work and children, and each question was answered |
| Examination | Pelvic, speculum and rectovaginal examination | At diagnosis; every three to six months for two years after treatment | Completed today | About 4.5 cm tumor; left parametrial spread not reaching the pelvic wall; vagina and rectum free |
| Imaging | Pelvic MRI | At staging, for local extent | Ordered | Within ten days |
| Imaging | FDG PET-CT | At staging; about three months after chemoradiation | Ordered | Within ten days, for nodes and distant spread |
| Laboratory | Kidney function (creatinine, eGFR) and magnesium for cisplatin | Before cisplatin, weekly during it, and after | Completed today | Creatinine 0.7 mg/dL, eGFR 117 |
| Laboratory | HIV and hepatitis C tests | At diagnosis | Ordered | Drawn today with her agreement |
| Laboratory | Blood count (hemoglobin, white cells, platelets) | About one month after starting oral iron, then every three months for a year; weekly during chemoradiation | Due | Hemoglobin 9.4 g/dL eight days ago; next at about one month |
| Survey | Pelvic pain score and analgesic safety (no anti-inflammatory painkillers with cisplatin) | Every visit | Completed today | 4 of 10; acetaminophen once or twice a day |
| Survey | PHQ-9 and GAD-7 | At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-up | Completed today | PHQ-9 9 (item 9 scored 0), GAD-7 9, on the day of diagnosis |
| Referral | Fertility and ovarian function counseling and her decision | Before cancer treatment begins | Completed today | Options explained; her decision due at the next visit |
| Referral | Oncology social worker and spiritual care | At diagnosis and through treatment | Completed today | Social worker met her today; spiritual care offered |

## Goal progress

- Diagnosis and stage explained to her directly, in Spanish, with time for questions, before any treatment decision. In progress; target 1951-03-02. **S**
- Hemoglobin 10 g/dL or more before radiation begins. In progress; target 1951-03-02. **S**
- Chemoradiation and brachytherapy completed within eight weeks. In progress; target 1951-05-18. **S**
- No evidence of disease on PET-CT and examination three months after treatment. In progress; target 1951-08-17. **S**
- PHQ-9 below 5 by six months. In progress; target 1951-08-17. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027), National Comprehensive Cancer Network
- Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)), International Federation of Gynecology and Obstetrics (International Journal of Gynecology and Obstetrics)
- Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017), American Society of Clinical Oncology (Journal of Clinical Oncology)
- Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018), American Society of Clinical Oncology (Journal of Clinical Oncology)
- Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023), American Society of Clinical Oncology (Journal of Clinical Oncology)
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge

## Follow-up

- Results of MRI, PET-CT, HIV and hepatitis C tests at a visit in about two weeks, with Dr. Osei-Bonsu, when the stage, treatment, and her fertility decision will be discussed. **S**
- Next scheduled visit 1951-03-02: staging results (pelvic MRI and PET-CT), FIGO stage, and her treatment and fertility decisions before chemoradiation. **S**
